Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Intimation for Intimation Of Board Meeting.

 PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as 'the Company') is scheduled to be held at the registered office of the company i.e. Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030 on Tuesday, the 30th day of May, 2023 at 04:30 P.M. inter alia, to: - Consider, approve and take on record the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March, 2023 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. - Consider and discuss any other routine matter or business of the company. You are requested to kindly take the same on your record and acknowledge receipt.
22-05-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Announcement under Regulation 30 (LODR)-Cessation

 With reference to Regulation 6(1) and Regulation 30 read with Clause 7 of Para A of Schedule III of the SEBI (LODR) Regulations, 2015 we do hereby inform that the Board of Directors of the company at their meeting held on Tuesday, 16th May, 2023 have appointed Ms. Sakshi Laller as a Whole Time Director (Promoter, Executive Director, Women Director), Mr. Vishwambhar Dayal Gupta as an Additional Director (Promoter, Non-Executive Director) and Mr. Bharat Singh as a Chief Financial Officer (CFO) (Key Managerial Personnel (KMP)) with effect from 16th May, 2023. Further Mr. Ramandeep Singh and Ms. Simmi Chhabra have tendered their resignation from the directorship of the company and Mr. Gursimran Singh has tendered his resignation as a Chief Financial Officer (CFO) (Key Managerial Personnel (KMP)) of the company with effect from 16th May, 2023. You are requested to kindly take the same on record and acknowledge receipt.
17-05-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Announcement under Regulation 30 (LODR)-Resignation of Director

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 16th May, 2023) which commenced at 11:00 A.M. and concluded at 04:30 P.M. have inter alia approved the following: 4. To accept the resignation of Mr. Ramandeep Singh (DIN: 07896086) as a Whole Time Director of the company with effect from 16th May, 2023. 5. To accept the resignation of Ms. Simmi Chhabra (DIN: 07870398) as an Independent Director of the company with effect from 16th May, 2023. You are requested to kindly take the same on your record and acknowledge receipt.
16-05-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 16th May, 2023) which commenced at 11:00 A.M. and concluded at 04:30 P.M. have inter alia approved the following: 6. To accept the resignation of Mr. Gursimran Singh (PAN: CAYPS2870L) as a Chief Financial Officer (CFO) (Key Managerial Personnel (KMP)) of the company with effect from 16th May, 2023. You are requested to kindly take the same on your record and acknowledge receipt.
16-05-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Announcement under Regulation 30 (LODR)-Cessation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 16th May, 2023) which commenced at 11:00 A.M. and concluded at 04:30 P.M. have inter alia approved the following: 4. To accept the resignation of Mr. Ramandeep Singh (DIN: 07896086) as a Whole Time Director of the company with effect from 16th May, 2023. 5. To accept the resignation of Ms. Simmi Chhabra (DIN: 07870398) as an Independent Director of the company with effect from 16th May, 2023. 6. To accept the resignation of Mr. Gursimran Singh (PAN: CAYPS2870L) as a Chief Financial Officer (CFO) (Key Managerial Personnel (KMP)) of the company with effect from 16th May, 2023. You are requested to kindly take the same on your record and acknowledge receipt.
16-05-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Announcement under Regulation 30 (LODR)-Meeting Updates

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 16th May, 2023) which commenced at 11:00 A.M. and concluded at 04:30 P.M. have inter alia approved the following: 1. To appoint Ms. Sakshi Laller (DIN: 10163397) as a Whole Time Director. 2. To appoint Mr. Vishwambhar Dayal Gupta (DIN: 00152580) as an Additional Director. 3. To appoint Mr. Bharat Singh (PAN: CCOPS5076E) as a Chief Financial Officer (CFO). 4. To accept the resignation of Mr. Ramandeep Singh (DIN: 07896086). 5. To accept the resignation of Ms. Simmi Chhabra (DIN: 07870398) as an Independent Director. 6. To accept the resignation of Mr. Gursimran Singh (PAN: CAYPS2870L) as a Chief Financial Officer (CFO) (Key Managerial Personnel (KMP)). 7. To appoint Mr. Harpreet Singh of M/s. S Harpreet and Associates, Chartered Accountants, as internal auditors of the company.
16-05-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Confirmation Regarding Non-Applicability Of Large Corporate Entity Framework.

 With reference to the SEBI circular number SEBI/HO/DDHS/CIR/P/2018/144 dated 26th December, 2018 (as updated from time to time) with reference to fund raising by issuance of debt securities by large corporate entities and disclosures thereof, it is informed that the company is 'not a large corporate entity' as on 31st March, 2023 as per the framework and applicability criteria provided in the circular(s) issued by SEBI. Therefore, the requirement of submission of requisite disclosures as specified in the circular(s) is not applicable on the company. You are requested to kindly take the same on your record and acknowledge the receipt.
29-04-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Undertaking Of Functional Website.

 This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The website address of the company is https://www.prismmedico.in. You are requested to kindly take the same on your record and acknowledge receipt.
28-04-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Submission Of Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2023.

 We herewith enclose a certificate issued by the Practicing Company Secretary for the financial year ended 31st March, 2023 pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. You are requested to kindly take the same on your record and acknowledge receipt.
28-04-2023
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Submission Of Compliance Certificate Certifying The Maintenance Of Physical And Electronic Share Transfer Facility As Per Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 During The Financial Year Ended 31St March, 2023.

 Pursuant to Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith certificate certifying the maintenance of physical and electronic share transfer facility during the financial year ended 31st March, 2023. You are requested to kindly take the same on your record and acknowledge the receipt.
28-04-2023
Next Page
Close

Let's Open Free Demat Account